Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Hemorrhage Is a Major Cause of Blood Transfusion in COVID-19 Patients

Cristina Sanz, MDPhD, Anabel Faundez, Registered nurse, Anna García Carulla, Registered nurse, Marta Rodriguez Aliberas, MD, Anny Coromoto, MD, Arturo Pereira, MD PhD

Blood (2020) 136 (Supplement 1): 21–22.

https://doi.org/10.1182/blood-2020-138830

Published: 2020

Journal Articles

Factors Associated with Mortality in Patients Experiencing First Episodes of Acquired Thrombotic Thrombocytopenic Purpura (aTTP). Results of the Spanish TTP Registry

Blood (2019) 134 (Supplement_1): 1082.

https://doi.org/10.1182/blood-2019-122665

Published: 2019

Journal Articles

Post-Transplant High-Dose Cyclophosphamide Overcomes the Detrimental Effect of a Single-Locus HLA Mismatched in Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation

Patricia Ferraz, MD, Arturo Pereira, MD PhD, María Suárez-Lledó, MD, Gonzalo Gutiérrez-García, MD, Francesc Fernández-Avilés, MD, Laura Rosinol, MD PhD, Teresa Solano, Noemí Llobet, Carla Ramos, Pedro Marín, MD, Alvaro Urbano-Ispizua, MD, Montserrat Rovira, MD, Carmen Martinez, MD PhD

Blood (2018) 132 (Supplement 1): 4576.

https://doi.org/10.1182/blood-2018-99-112985

Published: 2018

Journal Articles

Kinetics of Iron Depletion in Hereditary Hemochromatosis

Cristina Sanz, MD PhD, Anna Garcia-Carulla, Arturo Pereira, MD PhD

Blood (2018) 132 (Supplement 1): 3630.

https://doi.org/10.1182/blood-2018-99-110457

Published: 2018

Journal Articles

Therapy-Related MDS Can be Separated into Different Risk-Groups According to Tools for Classification and Prognostication of Primary MDS

Andrea Kuendgen, MD, Meritxell Nomdedeu, Heinz Tuechler, Guillermo Garcia-Manero, MD, Rami S. Komrokji, MD, Mikkael A. Sekeres, MD MS, Matteo Giovanni Della Porta, Alan F. List, MD, Mario Cazzola, Amy E. DeZern, MD, Gail J. Roboz, MD, David P. Steensma, MD, Arjan A. Van de Loosdrecht, MD PhD, Hartmut Döhner, MD, Xavier Calvo, MD, Sabine Blum, Arturo Pereira, MD PhD, Peter Valent, Dolors Costa, Aristoteles Giagounidis, Luis Benlloch, Uwe Platzbecker, Carme Pedro, MD, Michael Lübbert, Itziar Oiartzabal, Javier Grau, Maria Díez-Campelo, María Teresa Cedena, Sigrid Machherndl-Spandl, MD, Maria López-Pavía, Claudia D. Baldus, MD, Montserra Martinez-de-Sola, Reinhard Stauder, MD MSc, Brayan Merchan, Christina Ganster, Thomas Schroeder, Barbara Hildebrandt, Jordi Esteve, MD PhD, Benet Nomdedeu, Francesc Cobo, Francesc Sole, PhD, Rainer Haas, MD, Ulrich Germing, MD, Peter L Greenberg, MD, Detlef Haase, MD PhD, Guillermo Sanz

Blood (2018) 132 (Supplement 1): 3103.

https://doi.org/10.1182/blood-2018-99-118215

Published: 2018

Journal Articles

Excess Mortality in Polycythemia Vera and Essential Thrombocythemia

Arturo Pereira, MD PhD, Carlos Besses Raebel, MD PhD, Juan Carlos Hernandez Boluda, MD PhD, Francisca Ferrer Marin, MD PhD, Carmen Garcia-Hernandez, MD, María Teresa Gómez-Casares, MD PhD, Manuel Pérez-Encinas, MD, María-Soledad Noya, MD, Beatriz Cuevas, MD, Gonzalo Caballero, MD, Maribel Mata, Francisco Cervantes, MD PhD, Alberto Alvarez-Larrán, MD PhD

Blood (2018) 132 (Supplement 1): 3042.

https://doi.org/10.1182/blood-2018-99-109892

Published: 2018

Journal Articles

Feasibility of Treatment Discontinuation in Chronic Myeloid Leukemia in Clinical Practice in Spain: Results from a Nationwide Series of 236 Patients

Blood (2018) 132 (Supplement 1): 47.

https://doi.org/10.1182/blood-2018-99-109976

Published: 2018

Journal Articles

Comparison of Three Prognostic Scoring Systems in a Series of 146 Cases of Chronic Myelomonocytic Leukemia (CMML): MD Anderson Prognostic Score (MDAPS), CMML-Specific Prognostic Scoring System (CPSS) and Mayo Prognostic Model

Xavier Calvo, MD, Meritxell Nomdedeu, MD PhD, Rodrigo Santacruz, MD, Núria Martínez, MD, Dolors Costa, PhD, Arturo Pereira, MD PhD, Natalia Estrada, Blanca Xicoy, MD PhD, Jordi Esteve, MD PhD, Benet Nomdedeu, MD PhD

Blood (2014) 124 (21): 4660.

https://doi.org/10.1182/blood.V124.21.4660.4660

Published: 2014

Journal Articles

Clinical Features and Prognostic Assessment in 233 Patients with Therapy-Related Myelodysplastic Syndromes: The IPSS-R Is a Powerful Predictor of Outcome

Meritxell Nomdedeu, MD PhD, Xavier Calvo, MD, Arturo Pereira, MD PhD, Dolors Costa, PhD, Carmen Pedro, MD, Maria Teresa Cedena, MD, María López-Pavía, MD, Ana Africa Martín, MD, Montserrat Martínez de Sola, MD, Brayan Marcel Merchan, MD, Maria Teresa Ardanaz, MD, Jordi Esteve, MD PhD, Francesc Cobo, MD PhD, Guillermo F. Sanz, MD PhD, Benet Nomdedeu, MD PhD

Blood (2014) 124 (21): 4636.

https://doi.org/10.1182/blood.V124.21.4636.4636

Published: 2014

Journal Articles

Survival of Allogeneic Stem Cell Transplantation Vs Conventional Therapies per DIPSS Stratification in Patients with Primary Myelofibrosis Younger Than 65 Years: A Retrospective Analysis on 673 Patients

Nicolaus Kröger, MD, Toni Giorgino, PhD, Bart L Scott, MD, Marcus Ditschkowski, MD, Haefaa Alchalby, MD, Francisco Cervantes, MD PhD, Alessandro M. Vannucchi, MD, Mario Cazzola, MD, Enrica Morra, Tatjana Zabelina, MD, Margherita Maffioli, MD, Arturo Pereira, MD PhD, Dietrich Beelen, MD, H. Joachim Deeg, MD, Francesco Passamonti, MD

Blood (2014) 124 (21): 633.

https://doi.org/10.1182/blood.V124.21.633.633

Published: 2014

Journal Articles

Clinical Monoclonal B Lymphocytosis (cMBL), Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL): Diagnostic Criteria, Features At Diagnosis and Natural History

Rodrigo Santacruz, MD, Julio Delgado, MD, PhD, Tycho Baumann, MD, Maria Rozman, MD, Martha Aymerich, MD, Magda Pinyol, Arturo Pereira, MD, PhD, Cristina Royo, Alba Navarro, Cristina Lopez, Anna Carrió, PhD, Emili Montserrat, MD, PhD

Blood (2013) 122 (21): 5273.

https://doi.org/10.1182/blood.V122.21.5273.5273

Published: 2013

Journal Articles

Initial Characteristics, Treatment and Prognosis Of Elderly (≥ 70 years) Patients With Chronic Lymphocytic Leukemia (CLL): An Analysis Of a Series Of 367 Cases

Tycho Baumann, MD, Julio Delgado, MD, PhD, Rodrigo Santacruz, MD, Alejandra Martínez-Trillos, MD, Cristina Royo, PhD, Alba Navarro, PhD, Magdalena Pinyol, PhD, María Rozman, MD, PhD, Cristina López, PhD, Neus Villamor, MD, PhD, Marta Aymerich, MD, PhD, Arturo Pereira, MD, PhD, Anna Carrió, PhD, Emili Montserrat, MD, PhD

Blood (2013) 122 (21): 4155.

https://doi.org/10.1182/blood.V122.21.4155.4155

Published: 2013

Journal Articles

Evaluation Of Two Prognostic Scoring Systems For Chronic Myelomonocytic Leukemia (CMML): CMML-Specific Prognostic Scoring System (CPSS) and MD Anderson Prognostic Score (MDAPS) In A Series Of 122 Cases Of De Novo CMML

Xavier Calvo, MD, Meritxell Nomdedeu, MD, PhD, Dolors Costa, PhD, Arturo Pereira, MD, PhD, Núria Martínez, Jordi Esteve, MD, PhD, Blanca Xicoy, MD, PhD, Benet Nomdedeu, MD, PhD

Blood (2013) 122 (21): 2810.

https://doi.org/10.1182/blood.V122.21.2810.2810

Published: 2013

Journal Articles

Effect of the Number of Prognostically Relevant Mutated Genes on Survival and Leukemia Progression in Primary Myelofibrosis

Blood (2013) 122 (21): 104.

https://doi.org/10.1182/blood.V122.21.104.104

Published: 2013

Journal Articles

Cytoreduction Plus Low-Dose Aspirin Versus Cytoreduction in Monotherapy As Primary Prophylaxis of Thrombosis in Patients with Essential Thrombocythemia.

Alberto Alvarez-Larrán, Arturo Pereira, MD. PhD, Eduardo Arellano-Rodrigo, MD, PhD, Juan Carlos Hernández-Boluda, Francisco Cervantes, MD, Carlos Besses, MD, PhD

Blood (2012) 120 (21): 2828.

https://doi.org/10.1182/blood.V120.21.2828.2828

Published: 2012

Journal Articles

Prognostic Impact of Mutations in a Large Series of Patients with Myelofibrosis

Blood (2012) 120 (21): 431.

https://doi.org/10.1182/blood.V120.21.431.431

Published: 2012

Journal Articles

Leukemia Risk Models in Primary Myelofibrosis: An International Working Group Study,

Ayalew Tefferi, MD, Animesh Pardanani, MBBS, PhD, Naseema Gangat, MD, Kebede Begna, MD, Curtis A. Hanson, MD, Daniel L. Van Dyke, Ph.D., Domenica Caramazza, Alessandro M. Vannucchi, MD, Enrica Morra, Mario Cazzola, Arturo Pereira, MD. PhD, Francisco Cervantes, MD, Francesco Passamonti, MD

Blood (2011) 118 (21): 3833.

https://doi.org/10.1182/blood.V118.21.3833.3833

Published: 2011

Journal Articles

Chronic Lymphocytic Leukemia Associated with Autoimmune Hemolytic Anemia Is Characterized by a Distinctive miRNA Signature,

Gerardo Ferrer, Msc, Alfons Navarro, PhD, Kate E Hodgson, MBBS, MRCP, FRCPath, Dolors Colomer, MD. PhD, Marta Aymerich, MD. PhD, Tycho Baumann, MD, Arturo Pereira, MD. PhD, Mariano Monzó, MD, PhD, Carol Moreno, MD, PhD, Emili Montserrat, MD. PhD

Blood (2011) 118 (21): 3897.

https://doi.org/10.1182/blood.V118.21.3897.3897

Published: 2011

Journal Articles

Chemoimmunotherapy Improves Survival of Patients with Chronic Lymphocytic Leukemia,

Gabriela Ghita, MD, Julio Delgado, MD. PhD, Tycho Baumann, MD, Ivan Dlouhy, MD, Marta Aymerich, MD. PhD, Dolors Colomer, MD. PhD, María Rozman, Neus Villamor, MD. PhD, Natalia Creus, MD. PhD, Arturo Pereira, MD. PhD, Emili Montserrat, MD. PhD

Blood (2011) 118 (21): 3908.

https://doi.org/10.1182/blood.V118.21.3908.3908

Published: 2011

Journal Articles

Reversion of the Experimental Hemodilutional Coagulopathy Induced by Crystalloids and Colloids Using Different Coagulation Factor Concentrates

Carolina Caballo, Ana M Galan, Ph.D., Maribel Diaz-Ricart, PhD, Irene Lopez-Vilchez, Ph.D., Miguel Lozano, MD, PhD, Joan Cid, MD, PhD, Marcos Pino, Joan Beltran, MD, PhD, Misericordia Basora, MD, PhD, Arturo Pereira, MD. PhD, Gines Escolar, MD, PhD

Blood (2011) 118 (21): 4349.

https://doi.org/10.1182/blood.V118.21.4349.4349

Published: 2011

NARROW

Hemorrhage Is a Major Cause of Blood Transfusion in COVID-19 Patients

Factors Associated with Mortality in Patients Experiencing First Episodes of Acquired Thrombotic Thrombocytopenic Purpura (aTTP). Results of the Spanish TTP Registry

Post-Transplant High-Dose Cyclophosphamide Overcomes the Detrimental Effect of a Single-Locus HLA Mismatched in Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation

Kinetics of Iron Depletion in Hereditary Hemochromatosis

Therapy-Related MDS Can be Separated into Different Risk-Groups According to Tools for Classification and Prognostication of Primary MDS

Excess Mortality in Polycythemia Vera and Essential Thrombocythemia

Feasibility of Treatment Discontinuation in Chronic Myeloid Leukemia in Clinical Practice in Spain: Results from a Nationwide Series of 236 Patients

Comparison of Three Prognostic Scoring Systems in a Series of 146 Cases of Chronic Myelomonocytic Leukemia (CMML): MD Anderson Prognostic Score (MDAPS), CMML-Specific Prognostic Scoring System (CPSS) and Mayo Prognostic Model

Clinical Features and Prognostic Assessment in 233 Patients with Therapy-Related Myelodysplastic Syndromes: The IPSS-R Is a Powerful Predictor of Outcome

Survival of Allogeneic Stem Cell Transplantation Vs Conventional Therapies per DIPSS Stratification in Patients with Primary Myelofibrosis Younger Than 65 Years: A Retrospective Analysis on 673 Patients

Clinical Monoclonal B Lymphocytosis (cMBL), Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL): Diagnostic Criteria, Features At Diagnosis and Natural History

Initial Characteristics, Treatment and Prognosis Of Elderly (≥ 70 years) Patients With Chronic Lymphocytic Leukemia (CLL): An Analysis Of a Series Of 367 Cases

Evaluation Of Two Prognostic Scoring Systems For Chronic Myelomonocytic Leukemia (CMML): CMML-Specific Prognostic Scoring System (CPSS) and MD Anderson Prognostic Score (MDAPS) In A Series Of 122 Cases Of De Novo CMML

Effect of the Number of Prognostically Relevant Mutated Genes on Survival and Leukemia Progression in Primary Myelofibrosis

Cytoreduction Plus Low-Dose Aspirin Versus Cytoreduction in Monotherapy As Primary Prophylaxis of Thrombosis in Patients with Essential Thrombocythemia.

Prognostic Impact of Mutations in a Large Series of Patients with Myelofibrosis

Leukemia Risk Models in Primary Myelofibrosis: An International Working Group Study,

Chronic Lymphocytic Leukemia Associated with Autoimmune Hemolytic Anemia Is Characterized by a Distinctive miRNA Signature,

Chemoimmunotherapy Improves Survival of Patients with Chronic Lymphocytic Leukemia,

Reversion of the Experimental Hemodilutional Coagulopathy Induced by Crystalloids and Colloids Using Different Coagulation Factor Concentrates

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only